SUPRIAD owner Contact Information online
from Bayer Aktiengesellschaft
SUPRIAD
US serial number:85128518
Application filling date:Sep. 13, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Apr. 12, 2011
Publication date:Jan. 25, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign priority claimed:Yes
Foreign foreign application number:302010015107
Foreign foreign application filling date:Mar. 12, 2010
Foreign foreign registration number:302010015107
Foreign foreign registration date:Jun. 24, 2010
Foreign foreign application registration country:GERMANY
Foreign foreign expiration date:Mar. 31, 2020
Goods and services:For: pharmaceutical preparations for the treatment of skin diseases
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 44(e)
Services:pharmaceutical preparations for the treatment of skin diseases
Current owner owner name:Bayer Aktiengesellschaft
Current owner owner address:Kaiser-Wilhelm-Allee
51373 Leverkusen
GERMANY
Current owner legal entity type:aktiengesellschaft
Current owner state or country:GERMANY
Attorney name:Jennifer Fraser
Attorney email:trademarks@cblh.com
Attorney docket number:01426-01961
Attorney email authorized:No
Correspondent name address:JENNIFER FRASER
CONNOLLY BOVE LODGE & HUTZ LLP
PO BOX 2207
WILMINGTON,
DELAWARE
UNITED STATES
19899-2207
Correspondent phone:302-658-9141
Correspondent email:trademarks@cblh.com
Correspondent fax:302-658-5614
Correspondent email authorized:No
Domestic representative name:Jennifer Fraser
Domestic representative phone:302-658-9141
Domestic representative fax:302-658-5614
Domestic representative email:trademarks@cblh.com
Domestic representative email authorized SUPRIAD:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (124) Bayer Aktiengesellschaft (57) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (53) Windmill Health Products, LLC (46) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (34) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Jan. 25, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
